ID   FDCP Mix A4/LRARa403SN c.5
AC   CVCL_D1L5
DR   Wikidata; Q127380851
RX   Patent=US5830760;
RX   PubMed=1334022;
CC   Characteristics: IL3 dependent.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9864; RARA (Note=RARalpha403; truncated version AA 1-403).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2040 ! FDCP-Mix cl.A4
CA   Factor-dependent cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
RX   Patent=US5830760;
RA   Tsai S., Collins S.J.;
RT   "Creating novel hematopoietic cell lines by expressing altered
RT   retinoic acid receptors.";
RL   Patent number US5830760, 03-Nov-1998.
//
RX   PubMed=1334022; DOI=10.1101/gad.6.12a.2258;
RA   Tsai S., Bartelmez S.H., Heyman R., Damm K., Evans R., Collins S.J.;
RT   "A mutated retinoic acid receptor-alpha exhibiting dominant-negative
RT   activity alters the lineage development of a multipotent
RT   hematopoietic cell line.";
RL   Genes Dev. 6:2258-2269(1992).
//